DEXCOM
DexCom, Inc. is a leader in continuous glucose sensing technologies, and focuses 100% on these technologies. Founded in 1999, DexCom’s roots stem from the pioneering 1967 research on implanted glucose sensors at the University of Wisconsin. DexCom started with a focus on creating an implantable Sensor that the body would not reject and that would perform for a long period of time.
DEXCOM
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
1999-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.dexcom.com
Total Employee:
5001+
Status:
Active
Contact:
(888) 738-3646
Email Addresses:
[email protected]
Total Funding:
413.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Mobile Non Scaleable Content Organization Schema
Similar Organizations
AgaMatrix
AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Biolase
Biolase develops lasers and related products for providing biological treatments that reduce pain.
Apyx Medical
Apyx Medical manufactures digital electrosurgical generators and accessories for the operating room and surgicenter.
Cytek Biosciences
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
DJO Global
DJO Global is a manufacturer and distributor of medical devices for musculoskeletal health, vascular health, and pain management.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Establishment Labs
Establishment Labs, the next generation breast aesthetics company,
GT Urological
GT Urological, LLC develops, manufactures, distributes, and markets medical devices for the urinary incontinence market.
INDIBA, S.A.
INDIBA, S.A is specialising in the design, manufacture and distribution of products and devices for use by medical, physiotherapy.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Intuity Medical
Intuity Medical develops blood glucose monitoring systems for diabetes management.
LifeScan
LifeScan manufactures and markets blood glucose monitoring systems.
Lombard Medical plc
Lombard Medical develops, manufactures and markets an innovative range of minimally invasive abdominal.
Masimo
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products.
Metric Medical Devices
Metric Medical Devices develops, manufactures, and distributes orthopedic implant systems for musculoskeletal fixation.
Nucleix
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
OrthoPediatrics
OrthoPediactrics is a medical device company that develops and manufactures orthopedic implants for pediatric orthopedic surgeons.
Premier Filling Co.
Premier Filling develops, manufactures and fills bag-on-valve continuous spray products.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
SuperSonic Imagine
SuperSonic Imagine develops and manufactures ultrasound medical imaging systems for evaluating and visualizing tissue elasticity.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-08-22 | TypeZero Technologies | TypeZero Technologies acquired by Dexcom | N/A |
| 2016-05-02 | Nintamed | Nintamed acquired by Dexcom | N/A |
| 2012-02-29 | SweetSpot Diabetes Care | SweetSpot Diabetes Care acquired by Dexcom | 8.5 M USD |
Investors List
St. Paul Venture Capital
St. Paul Venture Capital investment in Series D - Dexcom
RWI Group
RWI Group investment in Series D - Dexcom
Warburg Pincus
Warburg Pincus investment in Series D - Dexcom
Canaan Partners
Canaan Partners investment in Series D - Dexcom
Windamere Venture Partners
Windamere Venture Partners investment in Series C - Dexcom
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Series C - Dexcom
St. Paul Venture Capital
St. Paul Venture Capital investment in Series C - Dexcom
Fog City Capital
Fog City Capital investment in Series C - Dexcom
RWI Group
RWI Group investment in Series C - Dexcom
Canaan Partners
Canaan Partners investment in Series C - Dexcom
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-06-17 | Current Health | Dexcom investment in Series A - Current Health | 3.32 M GBP |
| 2019-01-08 | Beta Bionics | Dexcom investment in Series B - Beta Bionics | 63 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-13 | iRhythm gets back on beat, tapping former Dexcom exec as CEO |
| 2020-03-11 | Dexcom appoints senior VP of finance and chief accounting officer |
Official Site Inspections
http://www.dexcom.com Semrush global rank: 8.65 K Semrush visits lastest month: 18.38 M
Unable to get host informations!!!
More informations about "Dexcom"
Dexcom - Wikipedia
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. See details»
DexCom, Inc. - Investor Relations
Jun 18, 2025 Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose …See details»
Dexcom - The Org
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with …See details»
DexCom Org Chart + Executive Team - The Official Board
The org chart of DexCom contains its 54 main executives like Kevin Sayer, Jereme Sylvain and Jacob Leach.See details»
Dexcom - Crunchbase Company Profile & Funding
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.See details»
About Dexcom Glucose Sensing and CGM Company
Dexcom is a leading glucose sensing and continuous glucose monitoring (CGM) manufacturer for diabetes management. Learn about Dexcom, their mission and values.See details»
Dexcom - Leadership Team | The Org
The Leadership Team at Dexcom is responsible for setting the strategic direction and overseeing the operational execution of the company's mission to revolutionize diabetes care through …See details»
What Is Dexcom? | Dexcom
Dexcom, Inc. is transforming diabetes care by providing superior continuous glucose monitoring (CGM) to help people better manage their diabetes. Learn more.See details»
DexCom, Inc. - Sustainability Overview
Dexcom seeks to exemplify quality in all aspects of the organization. While our end goal is the production of the highest-caliber CGM devices that empower people to take control of health, …See details»
Dexcom Executive Leadership | Dexcom
Dexcom's executive leadership team is passionate about bringing the latest in diabetes management technology to the world. Read their profiles here.See details»
DexCom, Inc. - Governance - Executive Management
Jon Coleman is Executive Vice President and Chief Commercial Officer at Dexcom. Jon joined Dexcom in 2025 and is responsible for Dexcom’s global commercial organization including …See details»
About Dexcom | Dexcom
Read about our story, mission, and values. Dexcom empowers people to take control of diabetes with an innovative continuous glucose monitoring (CGM) system.See details»
Dexcom Continuous Glucose Monitoring - The most accurate …
Dexcom G7 is our most powerful continuous glucose monitoring (CGM) system and also the most accurate CGM available.1 Period. Offering real-time glucose feedback and numerous partner …See details»
Dexcom Clarity
Jun 23, 2025 Dexcom Clarity software highlights your glucose patterns, trends and statistics. Share with your clinic and monitor improvements between visits. Clarity is an important part of …See details»
Dexcom CGM - Wikipedia
Dexcom G6 The Dexcom CGM is a continuous glucose monitoring system developed by Dexcom, a company specializing in glucose monitoring technology for individuals with diabetes. Several …See details»
DexCom, Inc. - Governance - Governance Documents
The Board of Directors of Dexcom (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound …See details»
DexCom, Inc. - Dexcom Reports Second Quarter 2025 Financial …
Jun 30, 2025 DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights: Revenue grew 15% …See details»
Dexcom beats estimates for quarterly results, names new CEO
21 hours ago Dexcom beat estimates for second-quarter results on Wednesday, driven by strong demand for its continuous glucose monitors, and named Jake Leach as its CEO.See details»
Dexcom Reports Second Quarter 2025 Financial Results ... - BioSpace
13 hours ago SAN DIEGO-- (BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2025. Second Quarter 2025 …See details»
Dexcom CEO Kevin Sayer to step down | MedTech Dive
1 day ago Dexcom CEO Kevin Sayer will step down after leading the diabetes tech company for a decade. Current Chief Operating Officer Jake Leach will become CEO on Jan. 1, 2026, and …See details»